![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
BURDEN OF COMORBIDITIES AND COMEDICATIONS IN A CHRONIC HCV POPULATION COMPARED WITH A NON-HCV POPULATION IN JAPAN BETWEEN 2015 AND 2016
|
|
|
Reported by Jules Levin
APASL March 14-17 2018 New Delhi
Daniel J. Ruzicka, M.D., M.Sc.1; Jumpei Tetsuka, M.Sc.1; Go Fujimoto, M.Sc.2; Tatsuya Kanto, M.D., Ph.D.3
1Medical Affairs, MSD K.K., Tokyo, Japan; 2Biostatistics and Research Decision Sciences, MSD K.K., Tokyo, Japan; 3The Research Center for Hepatitis and Immunology Department of Liver Disease, National Center for Global Health and Medicine, Ichikawa, Japan
![0321181](../images%20/032118/032118-16/0321181.gif)
![0321182](../images%20/032118/032118-16/0321182.gif)
![0321183](../images%20/032118/032118-16/0321183.gif)
![0321184](../images%20/032118/032118-16/0321184.gif)
![0321185](../images%20/032118/032118-16/0321185.gif)
![0321186](../images%20/032118/032118-16/0321186.gif)
![0321187](../images%20/032118/032118-16/0321187.gif)
![0321188](../images%20/032118/032118-16/0321188.gif)
![0321189](../images%20/032118/032118-16/0321189.gif)
![03211810](../images%20/032118/032118-16/03211810.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|